Northland Securities, the brokerage firm, has recently decreased the rating on STEC Inc (STEC). They lowered the rating from Outperform to Market Perform. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. The target price is currently set at $12 per share by the brokerage firm. Shares of STEC fell by 39.46% or $-6.59/share to $10.11. In the past year, the shares have traded as low as $10.95 and as high as $25.44. On average, 2037040 shares of STEC exchange hands on a given day and today's volume is recorded at 14667677.
Haemonetics (HAE) recently had their rating decreased from Outperform to Mkt Perform. Morgan Keegan is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bearish sign for the stock, and this brokerage house may tell its clients to sell the stock. The share prices may fall because of this action. Analysts believe that the company's share price may begin to fall. The target price is currently set at $76 per share by the brokerage firm. Shares of HAE fell by 0.26% or $-0.17/share to $65.01. In the past year, the shares have traded as low as $50.50 and as high as $70.40. On average, 143780 shares of HAE exchange hands on a given day and today's volume is recorded at 142946.
Ticonderoga, the brokerage firm, has recently decreased the rating on United Continental (UAL). They lowered the rating from Buy to Neutral. The brokerage firm believes the company is on the downswing and there could be potential savings or capital preservation in selling the stock now. Shares of UAL traded higher by 4.08% or $0.7007/share to $17.86. In the past year, the shares have traded as low as $17.06 and as high as $29.75. On average, 6908570 shares of UAL exchange hands on a given day and today's volume is recorded at 14667585.
STEC Inc (STEC) is currently being analyzed by the brokerage firm ThinkEquity. They have just changed their rating from Buy to Hold. This indicates that the company may not be doing as well as investors were expecting. Look for potential selling pressure or a downside move in the share price. Shares of STEC fell by 39.46% or $-6.59/share to $10.11. In the past year, the shares have traded as low as $10.95 and as high as $25.44. On average, 2037040 shares of STEC exchange hands on a given day and today's volume is recorded at 14667677.
RTI Biologics (RTIX) recently had their rating changed from Hold to Buy. The Benchmark Company is the brokerage firm which is currently analyzing this company and found it necessary to change their rating. This is usually a bullish sign for the company's share price, as these brokerages begin to tell their clients to start buying the upgraded stock. The shares may see a continued uptrend because of this. Analysts believe that the company's share price may begin to improve. The target price is currently set at $4 per share by the brokerage firm. Shares of RTIX traded higher by 0.62% or $0.02/share to $3.26. In the past year, the shares have traded as low as $2.02 and as high as $3.34. On average, 434427 shares of RTIX exchange hands on a given day and today's volume is recorded at 399949.
